Tue 18 May |
|
DAY 1 | Conference Hall | Workshop Room |
|
DAY 1 | Conference Hall | Workshop Room |
| ||
9:00 | 9:00: | ||||
9:05: | 9:05: | ||||
9:10: | 9:10: | ||||
9:15: | 9:15: | ||||
9:20: | 9:20: | ||||
9:25: | 9:25: | ||||
9:30: | 9:30: | ||||
9:35: | 9:35: | ||||
9:40: | 9:40: | ||||
9:45: | Conference welcome and Keynote Introduction 09:45 (5 mins) Johan Hyllner, AstraZeneca Combined cell and gene therapy for Epidermolysis Bullosa 09:50 (45 mins) Keynote Speaker: Michele De Luca, Centre for Regenerative Medicine “Stefano Ferrari” University of Modena and Reggio Emillia |
9:45: | |||
9:50: | 9:50: | ||||
9:55: | 9:55: | ||||
10:00 | 10:00 | ||||
10:05 | 10:05 | ||||
10:10 | 10:10 | ||||
10:15 | 10:15 | ||||
10:20 | 10:20 | ||||
10:25 | 10:25 | ||||
10:30 | 10:30 | ||||
10:35 | 10:35 | ||||
10:40 | 10:40 | ||||
10:45 | 10:45 | ||||
10:50 | 10:50 | ||||
10:55 | 10:55 | ||||
11:00 | 11:00 | ||||
11:05 | 11:05 | ||||
11:10 | 11:10 | ||||
11:15 | 11:15 | ||||
11:20 | 11:20 | ||||
11:25 | Session Chair Welcome 11:25 (5 mins) Johan Hyllner, AstraZeneca Developing a stem cell based therapy for Parkinson’s disease 11:30 (20 mins) Malin Parmar, Lund University
Overcome the most common challenges in cell & gene therapy development using Droplet Digital PCR 11:50 (15 mins) Rosario Tizzone — Bio-Rad Cartilage regeneration with cell therapy - current and future aspects 12:05 (20 mins) Anders Lindahl, Institute of Biomedicine, The Sahlgrenska Academy, |
11:25 | |||
11:30 | 11:30 | ||||
11:35 | 11:35 | ||||
11:40 | 11:40 | ||||
11:45 | 11:45 | ||||
11:50 | 11:50 | ||||
11:55 | 11:55 | ||||
12:00 | 12:00 | ||||
12:05 | 12:05 | ||||
12:10 | 12:10 | ||||
12:15 | 12:15 | ||||
12:20 | 12:20 | ||||
12:25 | 12:25 | ||||
12:30 | Joint Q&A Session 12:30 (20 mins) Malin Parmar, Lund University Anders Lindahl, Institute of Biomedicine, The Sahlgrenska Academy, |
12:30 | |||
12:35 | 12:35 | ||||
12:40 | 12:40 | ||||
12:45 | 12:45 | ||||
12:50 | 12:50 | ||||
12:55 | 12:55 | ||||
1:00 | 1:00: | ||||
1:05: | 1:05: | ||||
1:10: | 1:10: | ||||
1:15: | 1:15: | ||||
1:20: | 1:20: | ||||
1:25: | 1:25: | ||||
1:30: | 1:30: | ||||
1:35: | 1:35: | ||||
1:40: | 1:40: | ||||
1:45: | 1:45: | ||||
1:50: | 1:50: | ||||
1:55: | 1:55: | ||||
2:00 | 2:00: | ||||
2:05: | 2:05: | ||||
2:10: | Session Chair Welcome 14:10 (5 mins) Ryan Hicks, AstraZeneca Is the Cellular Secretome the Next Step of Cell Therapy? 14:15 (20 mins) Philippé Menasché, INSERM |
2:10: | |||
2:15: | 2:15: | ||||
2:20: | 2:20: | ||||
2:25: | 2:25: | ||||
2:30: | 2:30: | ||||
2:35: | 2:35: | ||||
2:40: | 2:40: | ||||
2:45: | 2:45: | ||||
2:50: | 2:50: | ||||
2:55: | 2:55: | ||||
3:00 | 3:00: | ||||
3:05: | VEGF-A modified mRNA in Cardiovascular Disease 15:05 (20 mins) Anna Collén, AstraZeneca |
3:05: | |||
3:10: | 3:10: | ||||
3:15: | 3:15: | ||||
3:20: | 3:20: | ||||
3:25: | 3:25: | ||||
3:30: | Regenerative Medicine in Diabetes: a work in progress 15:30 (20 mins) Lorenzo Piemonti , IRCCS Ospedale San Raffaele Joint Q&A Session 15:50 (20 mins) Philippé Menasché, INSERM Anna Collén, AstraZeneca Lorenzo Piemonti , IRCCS Ospedale San Raffaele |
3:30: | |||
3:35: | 3:35: | ||||
3:40: | 3:40: | ||||
3:45: | 3:45: | ||||
3:50: | 3:50: | ||||
3:55: | 3:55: | ||||
4:00 | 4:00: | ||||
4:05: | 4:05: | ||||
4:10: | 4:10: | ||||
4:15: | 4:15: | ||||
4:20: | 4:20: | ||||
4:25: | 4:25: | ||||
4:30: | 4:30: | ||||
4:35: | 4:35: | ||||
4:40: | 4:40: | ||||
4:45: | 4:45: | ||||
4:50: | 4:50: | ||||
4:55: | 4:55: | ||||
5:00 | 5:00: |